Red X iconGreen tick iconYellow tick icon

Contact Details

Phone
+64 21 854 423
Email
nicola.scott@otago.ac.nz
Position
Senior Research Fellow
Department
Department of Medicine (Christchurch)
Qualifications
BSc(Hons) PhD(Otago)
Research summary
Cardiovascular physiology in health and disease
Memberships
University of Otago Animal Ethics Committee

Research

Dr Scott is a Senior Research Fellow in the Christchurch Heart Institute.

As part of the CHI Large Animal Physiology team, Nicola has a special interest in the integrated cardiovascular, endocrine and renal control of pressure/volume homeostasis. Particular emphasis is placed on the role that key vasoactive hormones (such as the natriuretic peptides and the renin-angiotensin-aldosterone system) play in the pathophysiology of circulatory diseases such as hypertension, myocardial infarction and heart failure, and ways of manipulating these systems in order to prevent and treat these diseases

Research interests

  • Neurohormonal physiology and pathophysiology in cardiovascular health and disease
  • Integrative cardiovascular, endocrine and renal physiology of pressure / volume homeostasis
  • Bioactivity of vasoactive hormones
  • Pathophysiology of myocardial infarction and heart failure
  • Cardiac Imaging

Additional details

Heart Foundation of New Zealand Senior Fellowship, 2024

Publications

Scott, N. (2025, September). Phosphodiesterase-9 inhibition improves cardiac structure after myocardial infarction in an ovine model. Verbal presentation at the Queenstown Research Week (QRW) Heart Satellite Meeting, Christchurch, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs

Scott, N. J. A., Rademaker, M. T., Troughton, R. W., Richards, A. M., & Charles, C. J. (2024, August-September). Phosphodiesterase 9 inhibition: A novel treatment for low cardiac output heart failure: Sheep bridging the gap from mice to men. Verbal presentation at the 18th New Zealand Medical Sciences Congress (MedSci), Queenstown, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs

Scott, N. J. A., Charles, C. J., Prickett, T. C. R., Frampton, C. M., Richards, A. M., & Rademaker, M. T. (2024). Phosphodiesterase 9 inhibition combined with valsartan and with sacubitril/valsartan in experimental ovine heart failure. Journal of the American Heart Association, 13, e036689. doi: 10.1161/jaha.124.036689 Journal - Research Article

Janiak, P. P., Rademaker, M. T., Scott, N. J. A., Charles, C. J., Lawson, F. C., Ozoux, M. L., & Kowala, M. C. (2024). COR-1167, a new long-acting CRF2 receptor agonist, decreases congestion by improving cardiorenal function in a sheep model of worsening heart failure (WHF). European Journal of Heart Failure, 26(S2), (pp. 400). doi: 10.1002/ejhf.3326 Conference Contribution - Published proceedings: Abstract

Scott, N. J. A., Prickett, T. C. R., Charles, C. J., Espiner, E. A., Richards, A. M., & Rademaker, M. T. (2024). Haemodynamic, hormonal and renal actions of osteocrin in normal sheep. Experimental Physiology, 109, 1305-1316. doi: 10.1113/EP091826 Journal - Research Article

Back to top